Product information

Current status:

Cancelled Post Market

Current status date:

2001-11-05

Original market date: ^{See footnote 1}

1997-07-17

Product name:

HUMATROPE - 13.3MG

DIN:

02229693 Electronic product monograph is not available

Company:

ELI LILLY CANADA INC
SUITE 900 Exchange Tower, 130 King Street West
Toronto
Ontario
Canada M5X 1B1

Class:

Human

Dosage form(s):

Powder For Solution ,  Liquid

Route(s) of administration:

Intramuscular ,  Subcutaneous

Number of active ingredient(s):

2

Schedule(s):

Prescription ,  Schedule D

American Hospital Formulary Service (AHFS): ^{See footnote 3}

68:28.00 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

H01AC01 SOMATROPIN

Active ingredient group (AIG) number:^{See footnote5}

0231839002

Risk Management Plans ^{See footnote 7}

A Risk Management Plan (RMP) for this product was submitted.